| 1 | [SID24812061] | Active | EC50 | 0.0133 | Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4) [AID434937, Type: confirmatory] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 0.0133 [uM] | | BioAssay | Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4) | | AID | 434937 | | BioAssay type | confirmatory | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 2 | [SID24812061] | Active | EC50 | 0.40787 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 0.40787 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 3 | [SID24812061] | Active | EC50 | 0.40787 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 0.40787 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 4 | [SID24812061] | Active | EC50 | 7.495 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 7.495 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 5 | [SID24812061] | Active | EC50 | 7.495 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 7.495 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 6 | [SID24812061] | Active | EC50 | 7.495 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 7.495 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 7 | [SID24812061] | Active | EC50 | 7.495 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | EC50 | 7.495 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 8 | [SID24812061] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 9 | [SID24812061] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 10 | [SID24812061] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 11 | [SID24812061] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 12 | [SID24812061] | Active | | | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). [AID2237, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). | | AID | 2237 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 13 | [SID24812061] | Active | | | Confirmatory screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4) [AID2426, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4) | | AID | 2426 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 14 | [SID24812061] | Active | | | Second confirmatory screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4) [AID2461, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Active | | BioAssay | Second confirmatory screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4) | | AID | 2461 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 15 | [SID24812061] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID24812061] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 17 | [SID24812061] | Inactive | Potency | 4.4668 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 18 | [SID24812061] | Inactive | EC50 | 20.454 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | EC50 | 20.454 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 19 | [SID24812061] | Inactive | EC50 | 20.454 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | EC50 | 20.454 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 20 | [SID24812061] | Inactive | Potency | 22.3872 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID24812061] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 22 | [SID24812061] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 23 | [SID24812061] | Inactive | EC50 | 92.451 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | EC50 | 92.451 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 24 | [SID24812061] | Inactive | EC50 | 92.451 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | EC50 | 92.451 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 25 | [SID24812061] | Inactive | EC50 | 92.451 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | EC50 | 92.451 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 26 | [SID24812061] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 27 | [SID24812061] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 28 | [SID24812061] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 29 | [SID24812061] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 30 | [SID24812061] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 31 | [SID24812061] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 32 | [SID24812061] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 33 | [SID24812061] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 34 | [SID24812061] | Inactive | | | Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells [AID1296, Type: screening] | proinsulin [Homo sapiens] [gi:59036749] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells | | AID | 1296 | | BioAssay type | screening | | Target | proinsulin [Homo sapiens] [gi:59036749] | | PubMed | | | Data Table |  |
|
| 35 | [SID24812061] | Inactive | | | Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells [AID1296, Type: screening] | proinsulin [Homo sapiens] [gi:59036749] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells | | AID | 1296 | | BioAssay type | screening | | Target | proinsulin [Homo sapiens] [gi:59036749] | | PubMed | | | Data Table |  |
|
| 36 | [SID24812061] | Inactive | | | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells [AID1273, Type: screening] | proinsulin [Homo sapiens] [gi:59036749] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells | | AID | 1273 | | BioAssay type | screening | | Target | proinsulin [Homo sapiens] [gi:59036749] | | PubMed | | | Data Table |  |
|
| 37 | [SID24812061] | Inactive | | | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells [AID1273, Type: screening] | proinsulin [Homo sapiens] [gi:59036749] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells | | AID | 1273 | | BioAssay type | screening | | Target | proinsulin [Homo sapiens] [gi:59036749] | | PubMed | | | Data Table |  |
|
| 38 | [SID24812061] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 39 | [SID24812061] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 40 | [SID24812061] | Inactive | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 41 | [SID24812061] | Inactive | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 42 | [SID24812061] | Inactive | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 43 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 44 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 45 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 46 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 47 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 48 | [SID24812061] | Inactive | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen [AID1918, Type: screening] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen | | AID | 1918 | | BioAssay type | screening | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 49 | [SID24812061] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 50 | [SID24812061] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24812061 | | CID | 5113104 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|